We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Avacta Announces First Clinical Data for Its SARS-CoV-2 Rapid Antigen Test

Product News   Feb 16, 2021

 
Avacta Announces First Clinical Data for Its SARS-CoV-2 Rapid Antigen Test

Credit: PIRO4D/ pixabay

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

BellBrook Labs Awarded Phase II Grant to Develop Drugs for Lupus and Related Autoimmune Diseases

Product News

BellBrook Labs has been awarded a $1.8 million Phase II SBIR grant for the treatment of lupus and other autoimmune diseases.

READ MORE

Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Product News

Avacta Group plc has announced positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test.

READ MORE

Adaptate Biotherapeutics Raises $18 million in Series A2 Funding

Product News

Adaptate Biotherapeutics has announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited have together made a further equity investment of $18 million.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE